A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12365878
Conclusion of this study
Treatment with ethyl-eicosapentaenoate at a dosage of 1 g/d was effective in treating depression in patients who remained depressed despite adequate standard therapy.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study